Tag: implantable-bci

3 articles

Industry News

NeuroXess says its Mandarin-decoding brain implant runs at 300 characters a minute, faster than native speech

Shanghai-based NeuroXess says a 35-year-old woman with epilepsy fitted with its 256-channel surface-cortex implant has been decoded reading Mandarin at 300 characters per minute through a large language model layer, faster than the roughly 220 cpm rate of a native Mandarin first-language speaker. Co-founder and chief scientist Tiger Tao disclosed the figure to Nature on 19 May 2026. The underlying paper has not yet been published, but the result sits on top of NeuroXess's already peer-reviewed Science Advances paper from 5 November 2025 (71.2% accuracy across 394 Mandarin syllables in a 43-year-old woman with epilepsy).

May 28

Market Moves

Axoft draws C.P. Group lead in $55M Series A as US BCI company runs first acute implant in Shanghai

Cambridge, Massachusetts implantable BCI company Axoft closed a $55M oversubscribed Series A on April 29, led by Thai conglomerate Charoen Pokphand's strategic arm C.P. Group Innovation with Chinese co-investors Hillhouse and Gaorong, alongside US participants Alumni Ventures and Stanford. The same announcement disclosed Axoft's first acute intraoperative test of its Fleuron polymer probe in a Shanghai patient — the first publicly confirmed clinical use of a US BCI material in China, with more Chinese trials planned this year.

Apr 29